HLA and KIR Region Genomics in Immune-Mediated Diseases (U19)

Funding Opportunity RFA-AI-14-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLAGC), formerly the HLA Region Genomics in Immune-Mediated Diseases Consortium.This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding